Cargando…
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
Demyelinating syndrome secondary to systemic lupus erythematosus (DS-SLE) is a rare encephalomyelitis burden with a high risk of disability and death. We report on a 49-year-old Caucasian woman with systemic lupus erythematosus (SLE) complicated by severe cognitive dysfunction, brainstem disease, cr...
Autores principales: | Chessa, Elisabetta, Piga, Matteo, Floris, Alberto, Mathieu, Alessandro, Cauli, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602683/ https://www.ncbi.nlm.nih.gov/pubmed/28979169 http://dx.doi.org/10.2147/OARRR.S143768 |
Ejemplares similares
-
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus
por: Cocco, Cristina, et al.
Publicado: (2023) -
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
por: Piga, Matteo, et al.
Publicado: (2017) -
Neuropsychiatric Lupus and Lupus Nephritis Successfully Treated with Combined IVIG and Rituximab: An Alternative to Standard of Care
por: Cheikh, Mohamed M., et al.
Publicado: (2022) -
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018) -
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review
por: Chessa, Elisabetta, et al.
Publicado: (2021)